Clinical predictors of response in metastatic germ cell tumors
โ Scribed by Grant Taylor; David J. Perry; Robert D. Knight; Nancy A. Dawson; Steven J. Skoog; David G. McLeod
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 556 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
As Professor D'Angio points out in his introduction, Dr. Willoughby and his colleagues are to be congratulated on the successful outcome of this young girl's management [ 11. However, we would be grateful to have their comments on the following queries: 1. Why was attempted "tissue diagnosis," whic
Eighty-two patients with metastatic germ cell tumors (GCT) treated with two-drug therapy consisting of etoposide and cisplatin were evaluated for late relapse. Goodrisk GCT was defined using Memorial Sloan-Kettering Cancer Center (MSKCC) criteria. Etoposide was given a t 100 mg/mz on days 1 to 5 and
Cancer. Patients who present with widely metastatic germ cell tumors (GCTs) are characteristically treated with cisplatin-based chemotherapy. Depending on the patient population selected, approximately 70% of these patients will obtain a complete clinical response, with normalization of serum tumor